Back to Stakeholders
Research, Drug Development & ManufacturingAcademic & Non-Profit Research
Research, Drug Development & ManufacturingAcademic & Non-Profit ResearchUniversities and Colleges with Dedicated Psychedelic Research Groups
Research, Drug Development & Manufacturing

University of New Mexico

University of New Mexico, Albuquerque, United States
8 Trials

Pioneer in modern American psychedelic research through Rick Strassman's DMT and psilocybin studies in the 1990s — among the first human psychedelic research since the 1970s. Today, UNM Health Sciences conducts active trials of psilocybin, MDMA, and ketamine for depression, PTSD, alcohol use disorder, and methamphetamine addiction.

Academic Research

0 papers

Published Papers

0

Trial Involvement

8

Distinct Focus Topics

0

Latest Publication

Unknown

Quick Facts

Type
Other
HQ
University of New Mexico, Albuquerque, United States
Website
Visit

Sponsored Trials

7
WithdrawnII

Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies

Start Date
Compounds
Placebo, Psilocybin
Not yet recruitingI

Group Psilocybin-Assisted Therapy for Post-Traumatic Stress Disorder

Start Date
Compounds
Psilocybin
RecruitingII

MDMA for Co-occurring PTSD and OUD After Childbirth

Start Date
Compounds
MDMA
WithdrawnI, II

Connectivity Changes Associated With Ketamine Assisted Psychotherapy for PTSD

Start Date
Compounds
Ketamine
CompletedI

EEG Characteristics in ECT

Start Date
Compounds
Placebo, Ketamine
CompletedI

Spreading Depolarization and Ketamine Suppression

Start Date
Compounds
Ketamine
CompletedII

Effects and Therapeutic Potential of Psilocybin in Alcohol Dependence

Start Date
Compounds
Psilocybin

Collaborated Trials

1
CompletedII

A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence

Start Date
Compounds
Psilocybin, Placebo